{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:14Z","timestamp":1790787494360,"version":"4.1.0"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,3,4]]},"DOI":"10.18632\/aging.102862","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T01:40:26Z","timestamp":1583372426000},"page":"4178-4192","source":"Crossref","is-referenced-by-count":40,"title":["SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity"],"prefix":"10.18632","volume":"12","author":[{"given":"Xiaojun","family":"Feng","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suowen","family":"Xu","sequence":"additional","affiliation":[{"name":"Aab Cardiovascular Research Institute, University of Rochester, West Henrietta, NY 14586, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Geng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizong","family":"Shen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR. China"},{"name":"Anhui Provincial Cardiovascular Institute, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Shaoxing University, Shaoxing, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, PR. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/med.21438","article-title":"Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen.","volume":"3","author":"Xu","year":"2018","journal-title":"Med Res Rev"},{"key":"2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/med.21300","article-title":"Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.","volume":"3","author":"Liu","year":"2014","journal-title":"Med Res Rev"},{"key":"3","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.7150\/thno.21966","article-title":"Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.","volume":"8","author":"Jin","year":"2018","journal-title":"Theranostics"},{"key":"4","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.","volume":"13","author":"Fornage","year":"2018","journal-title":"Circulation"},{"key":"5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy.","volume":"1","author":"Sadoshima","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.7150\/ijbs.26215","article-title":"Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy.","volume":"1","author":"Wang","year":"2018","journal-title":"Int J Biol Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"610846","DOI":"10.1155\/2015\/610846","article-title":"Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases.","volume":"201","author":"Zhu","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphar.2017.00361","article-title":"Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene.","volume":"8","author":"Zhu","year":"2017","journal-title":"Front Pharmacol"},{"key":"9","doi-asserted-by":"publisher","first-page":"15427","DOI":"10.1038\/s41598-017-14692-3","article-title":"Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection.","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci Rep"},{"key":"10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fphar.2018.00550","article-title":"The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.","volume":"9","author":"Shi","year":"2018","journal-title":"Front Pharmacol"},{"key":"11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","article-title":"Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.","volume":"2","author":"Szab\u00f3","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/bies.20085","article-title":"The PARP superfamily.","volume":"2","author":"de Murcia","year":"2004","journal-title":"BioEssays"},{"key":"13","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1038\/sj.onc.1202823","article-title":"Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro.","volume":"1","author":"Noda","year":"1999","journal-title":"Oncogene"},{"key":"14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/0006-291X(87)90934-X","article-title":"Poly (ADP-ribose) synthetase is phosphorylated by protein kinase C in vitro.","volume":"14","author":"Kamiya","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.cdd.4402088","article-title":"c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation.","volume":"1","author":"Shen","year":"2007","journal-title":"Cell Death Differ"},{"key":"16","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.1073\/pnas.0508606103","article-title":"Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1\/2.","volume":"10","author":"Swanson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"17","doi-asserted-by":"publisher","first-page":"40450","DOI":"10.1074\/jbc.M507553200","article-title":"Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription.","volume":"28","author":"Hottiger","year":"2005","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1128\/MCB.00121-09","article-title":"SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1.","volume":"2","author":"Gupta","year":"2009","journal-title":"Mol Cell Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1111\/bph.13091","article-title":"The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.","volume":"17","author":"Liu","year":"2015","journal-title":"Br J Pharmacol"},{"key":"20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yexcr.2018.10.003","article-title":"PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1\u03b1 axis.","volume":"37","author":"Hochhauser","year":"2018","journal-title":"Exp Cell Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/FJC.0b013e3181855cef","article-title":"Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.","volume":"5","author":"Halmosi","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun.","volume":"1","author":"Lombard","year":"2012","journal-title":"Nat Med"},{"key":"23","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/JCI39162","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice.","volume":"11","author":"Gupta","year":"2009","journal-title":"J Clin Invest"},{"key":"24","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1073\/pnas.250422697","article-title":"Silent information regulator 2 family of NAD- dependent histone\/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.","volume":"9","author":"Denu","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function.","volume":"40","author":"Sinclair","year":"2007","journal-title":"Biochem J"},{"key":"26","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1091\/mbc.e05-01-0033","article-title":"Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.","volume":"1","author":"Horikawa","year":"2005","journal-title":"Mol Biol Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.tem.2016.07.004","article-title":"Sirtuins in Cardiovascular Health and Diseases.","volume":"2","author":"Jin","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pharmthera.2018.11.003","article-title":"Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.","volume":"19","author":"Jin","year":"2019","journal-title":"Pharmacol Ther"},{"key":"29","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1128\/MCB.00822-12","article-title":"SIRT3 functions in the nucleus in the control of stress-related gene expression.","volume":"3","author":"Reinberg","year":"2012","journal-title":"Mol Cell Biol"},{"key":"30","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1128\/MCB.01636-07","article-title":"Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.","volume":"2","author":"Hirschey","year":"2007","journal-title":"Mol Cell Biol"},{"key":"31","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway.","volume":"28","author":"Gupta","year":"2010","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1128\/MCB.00426-08","article-title":"SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70.","volume":"2","author":"Gupta","year":"2008","journal-title":"Mol Cell Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","article-title":"Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction.","volume":"14","author":"Prolla","year":"2010","journal-title":"Cell"},{"key":"34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease.","volume":"2","author":"Runge","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/aps.2016.159","article-title":"Synthesis of the novel PARP-1 inhibitor AG-690\/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.","volume":"3","author":"Liu","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1101\/gad.183509.111","article-title":"On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.","volume":"2","author":"Kraus","year":"2012","journal-title":"Genes Dev"},{"key":"37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.","volume":"5","author":"Szab\u00f3","year":"2002","journal-title":"Pharmacol Rev"},{"key":"38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev.biochem.73.011303.073651","article-title":"The Sir2 family of protein deacetylases.","volume":"7","author":"Guarente","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cardiores.2003.09.029","article-title":"Poly(ADP-ribose) polymerase activation in the reperfused myocardium.","volume":"6","author":"Szab\u00f3","year":"2004","journal-title":"Cardiovasc Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2005.02.017","article-title":"Cardioprotective effects of poly(ADP-ribose) polymerase inhibition.","volume":"5","author":"Szab\u00f3","year":"2005","journal-title":"Pharmacol Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","article-title":"Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.","volume":"29","author":"Gupta","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1124\/jpet.108.143719","article-title":"A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.","volume":"32","author":"Lee","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cvr\/cvp144","article-title":"PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.","volume":"8","author":"Toth","year":"2009","journal-title":"Cardiovasc Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.bbamcr.2016.09.019","article-title":"The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.","volume":"186","author":"Liu","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ab.2003.11.015","article-title":"An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.","volume":"32","author":"Hergenrother","year":"2004","journal-title":"Anal Biochem"},{"key":"46","doi-asserted-by":"publisher","first-page":"H486","DOI":"10.1152\/ajpheart.00437.2004","article-title":"Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure.","volume":"28","author":"Gupta","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mce.2014.05.010","article-title":"AG-690\/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.","volume":"39","author":"Liu","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.yjmcc.2018.08.018","article-title":"Increased expression of DRAM1 confers myocardial protection against ischemia via restoring autophagy flux.","volume":"12","author":"Luo","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mce.2010.07.023","article-title":"Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-\u03baB signaling pathway.","volume":"33","author":"Huang","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.abb.2011.11.024","article-title":"PPAR\u03b1 activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.","volume":"51","author":"Liu","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.mce.2009.11.003","article-title":"Regulated expression of endothelial lipase in atherosclerosis.","volume":"31","author":"Liu","year":"2010","journal-title":"Mol Cell Endocrinol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:04:33Z","timestamp":1599077073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3,15]]}},"alternative-id":["102862","32139662"],"URL":"https:\/\/doi.org\/10.18632\/aging.102862","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]}}}